CardioVascular and Interventional Radiology

, Volume 36, Issue 1, pp 166–175 | Cite as

Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases

  • Xiaodong Wang
  • Constantinos T. SofocleousEmail author
  • Joseph P. Erinjeri
  • Elena N. Petre
  • Mithat Gonen
  • Kinh G. Do
  • Karen T. Brown
  • Anne M. Covey
  • Lynn A. Brody
  • William Alago
  • Raymond H. Thornton
  • Nancy E. Kemeny
  • Stephen B. Solomon
Clinical Investigation



This study was designed to evaluate the relationship between the minimal margin size and local tumor progression (LTP) following CT-guided radiofrequency ablation (RFA) of colorectal cancer liver metastases (CLM).


An institutional review board-approved, HIPPA-compliant review identified 73 patients with 94 previously untreated CLM that underwent RFA between March 2003 and May 2010, resulting in an ablation zone completely covering the tumor 4–8 weeks after RFA dynamic CT. Comparing the pre- with the post-RFA CT, the minimal margin size was categorized to 0, 1–5, 6–10, and 11–15 mm. Follow-up included CT every 2–4 months. Kaplan–Meier methodology and Cox regression analysis were used to evaluate the effect of the minimal margin size, tumor location, size, and proximity to a vessel on LTP.


Forty-five of 94 (47.9 %) CLM progressed locally. Median LTP-free survival (LPFS) was 16 months. Two-year LPFS rates for ablated CLM with minimal margin of 0, 1–5 mm, 6–10 mm, 11–15 mm were 26, 46, 74, and 80 % (p < 0.011). Minimal margin (p = 0.002) and tumor size (p = 0.028) were independent risk factors for LTP. The risk for LTP decreased by 46 % for each 5-mm increase in minimal margin size, whereas each additional 5-mm increase in tumor size increased the risk of LTP by 22 %.


An ablation zone with a minimal margin uniformly larger than 5 mm 4–8 weeks postablation CT is associated with the best local tumor control.


Ablation Radiofrequency ablation Minimal margin Local tumor progression Colon cancer liver metastasis Image guided CT guided Ablation margin evaluation method 



This work was supported in part by NIH Grant No. 5R21CA131763.

Conflict of interest

Authors Xiaodong Wang, Constantinos T. Sofocleous, Joseph P. Erinjeri, Elena N. Petre, Mithat Gonen, Kinh G. Do, Karen T. Brown, Anne M. Covey, Lynn A. Brody, William Alago, Raymond H. Thornton, and Kemeny NE have no conflict of interest to declare. Stephen B. Solomon—consultant for Covidien (Mansfield, MA) and Johnson and Johnson (Piscataway, NJ) and has a research contract with GE Healthcare (Milwaukee, WI).


  1. 1.
    Berber E, Siperstein A (2008) Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol 15(10):2757–2764PubMedCrossRefGoogle Scholar
  2. 2.
    Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg 25(6):445–460PubMedCrossRefGoogle Scholar
  3. 3.
    Leen E, Horgan PG (2007) Radiofrequency ablation of colorectal liver metastases. Surg Oncol 16(1):47–51PubMedCrossRefGoogle Scholar
  4. 4.
    Ayav A, Germain A, Marchal F et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200(4):435–439PubMedCrossRefGoogle Scholar
  5. 5.
    Sofocleous C, Nascimento R, Petrovic L et al (2008) Histopathology of tissue extracted on the probe after radiofrequency ablation of liver malignancy can predict local progression: initial results. Radiology 249(1(Oct)):364–374PubMedCrossRefGoogle Scholar
  6. 6.
    Kim YS, Rhim H, Cho OK, Koh BH, Kim Y (2006) Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 59(3):432–441PubMedCrossRefGoogle Scholar
  7. 7.
    Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg Oncol 242:158–171CrossRefGoogle Scholar
  8. 8.
    Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195(3):758–765PubMedCrossRefGoogle Scholar
  9. 9.
    Okuwaki Y, Nakazawa T, Shibuya A et al (2008) Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol 43(1):71–78PubMedCrossRefGoogle Scholar
  10. 10.
    Nakazawa T, Kokubu S, Shibuya A et al (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188(2):480–488PubMedCrossRefGoogle Scholar
  11. 11.
    Liu CH, Arellano RS, Uppot RN, Samir AE, Gervais DA, Mueller PR (2010) Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20(4):877–885PubMedCrossRefGoogle Scholar
  12. 12.
    Frich L, Hagen G, Brabrand K et al (2007) Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis. J Vasc Interv Radiol 18(9):1134–1140PubMedCrossRefGoogle Scholar
  13. 13.
    Crocetti L, de Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol 33(1):11–17PubMedCrossRefGoogle Scholar
  14. 14.
    Goldberg SN, Grassi CJ, Cardella JF et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20(7 Suppl):S377–S390PubMedCrossRefGoogle Scholar
  15. 15.
    Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS (2008) Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 190(6):1544–1551PubMedCrossRefGoogle Scholar
  16. 16.
    Fujioka C, Horiguchi J, Ishifuro M et al (2006) A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. Acad Radiol 13(8):986–994PubMedCrossRefGoogle Scholar
  17. 17.
    Schraml C, Clasen S, Schwenzer NF et al (2008) Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging 33(6):643–651PubMedCrossRefGoogle Scholar
  18. 18.
    Kim KW, Lee JM, Klotz E et al (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196(5):W565–W572PubMedCrossRefGoogle Scholar
  19. 19.
    Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235(3):728–739PubMedCrossRefGoogle Scholar
  20. 20.
    Choi H, Loyer EM, DuBrow RA et al (2001) Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21(Spec No):S41–S54PubMedGoogle Scholar
  21. 21.
    Pua BB, Sofocleous CT (2010) Imaging to optimize liver tumor ablation. Imaging Med 2(4):433–443CrossRefGoogle Scholar
  22. 22.
    Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15(3):938–946PubMedGoogle Scholar
  23. 23.
    Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics 2003. CA Cancer J Clin 53(1):5–26PubMedCrossRefGoogle Scholar
  24. 24.
    Kulaylat MN, Gibbs JF (2010) Thermoablation of colorectal liver metastasis. J Surg Oncol 101(8):699–705PubMedCrossRefGoogle Scholar
  25. 25.
    Kuvshinoff BW, Ota DM (2002) Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 132(4):605–611 discussion 611-612PubMedCrossRefGoogle Scholar
  26. 26.
    Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA (2003) Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 10(9):1059–1069PubMedCrossRefGoogle Scholar
  27. 27.
    Sofocleous CT, Petre EN, Gonen M et al (2011) CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol 22(6):755–761PubMedCrossRefGoogle Scholar
  28. 28.
    Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I (2003) Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90(10):1240–1243PubMedCrossRefGoogle Scholar
  29. 29.
    Machi J, Oishi AJ, Sumida K et al (2006) Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12(4):318–326PubMedCrossRefGoogle Scholar
  30. 30.
    Elias D, De Baere T, Smayra T, Ouellet JF, Roche A, Lasser P (2002) Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 89(6):752–756PubMedCrossRefGoogle Scholar
  31. 31.
    Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19(5):1206–1213PubMedCrossRefGoogle Scholar
  32. 32.
    Hur H, Ko YT, Min BS et al (2009) Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 197(6):728–736PubMedCrossRefGoogle Scholar
  33. 33.
    Sorensen SM, Mortensen FV, Nielsen DT (2007) Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol (Stockholm, Sweden: 1987) 48(3):253–258CrossRefGoogle Scholar
  34. 34.
    Vogl TJ, Straub R, Eichler K, Sollner O, Mack MG (2004) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy–local tumor control rate and survival data. Radiology 230(2):450–458PubMedCrossRefGoogle Scholar
  35. 35.
    Hayashi M, Inoue Y, Komeda K et al (2010) Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg 10:27PubMedCrossRefGoogle Scholar
  36. 36.
    de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248(4):626–637PubMedGoogle Scholar
  37. 37.
    de Jong MC, Pulitano C, Ribero D et al (2009) Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250(3):440–448PubMedGoogle Scholar
  38. 38.
    Are C, Gonen M, Zazzali K et al (2007) The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246(2):295–300PubMedCrossRefGoogle Scholar
  39. 39.
    Sofocleous CT, Klein KM, Hubbi B et al (2004) Histopathologic evaluation of tissue extracted on the radiofrequency probe after ablation of liver tumors: preliminary findings. AJR Am J Roentgenol 183(1):209–213PubMedGoogle Scholar
  40. 40.
    Snoeren N, Jansen MC, Rijken AM et al (2009) Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours. Dig Surg 26(1):56–62PubMedCrossRefGoogle Scholar
  41. 41.
    Snoeren N, Huiskens J, Rijken AM et al (2011) Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol 18(13):3702–3710PubMedCrossRefGoogle Scholar
  42. 42.
    Sofocleous CT, Garg S, Petrovic LM et al (2012) Ki-67 is a Prognostic Biomarker of Survival after Radiofrequency Ablation of Liver Malignancies (In Press)Google Scholar
  43. 43.
    Lu DS, Raman SS, Limanond P et al (2003) Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 14(10):1267–1274PubMedCrossRefGoogle Scholar
  44. 44.
    Keil S, Bruners P, Schiffl K et al (2010) Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Cardiovasc Intervent Radiol 33(2):297–306PubMedCrossRefGoogle Scholar
  45. 45.
    Wood BJ, Locklin JK, Viswanathan A et al (2007) Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J Vasc Interv Radiol 18(1 Pt 1):9–24PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2012

Authors and Affiliations

  • Xiaodong Wang
    • 1
    • 2
  • Constantinos T. Sofocleous
    • 1
    Email author
  • Joseph P. Erinjeri
    • 1
  • Elena N. Petre
    • 1
  • Mithat Gonen
    • 3
  • Kinh G. Do
    • 4
  • Karen T. Brown
    • 1
  • Anne M. Covey
    • 1
  • Lynn A. Brody
    • 1
  • William Alago
    • 1
  • Raymond H. Thornton
    • 1
  • Nancy E. Kemeny
    • 5
  • Stephen B. Solomon
    • 1
  1. 1.Section of Interventional Radiology, Department of RadiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of Interventional RadiologyPeking University Cancer Hospital and Institute, Key Laboratory of Carcinogenesis and Translational Research, Ministry of EducationBeijingChina
  3. 3.Department of Epidemiology and BiostatisticsMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  4. 4.Department of RadiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  5. 5.Department of MedicineMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations